This question has been answered by the relevant Government Department.
Question text
Baroness Finlay of Llandaff to ask His Majesty's Government what assessment they have made of the negative impact on pharmaceutical research investment in the UK of the refusal by National Institute for Health and Care Excellence to approve tofersen for SOD-1 MND patients in the UK. HL3732
Legend for business item text
† Item that is new or altered.
* Item is an oral question.
Numbers starting HL are unique identifiers for written questions, Bills or papers.
Member's Registered Interests
There are no interests to show.
Main Member
Baroness Finlay of Llandaff
Crossbench
Life peer